Article
Poor outcome of pediatric patients with acute myeloid leukemia harboring high FLT3/ITD allelic ratios.
Nature communications - 27 Jun 2022
Qiu Kun-Yin, Liao Xiong-Yu, Liu Yong, Huang Ke, Li Yang, Fang Jian-Pei, Zhou Dun-Hua
Abstract excerpt
Activating FLT3 mutations are the most common mutations in acute myeloid leukemia (AML), but the optimal threshold of FLT3/ITD allelic ratio (AR) among pediatric AML patients remains controversial. Here, we present the outcome and prognostic significance of FLT3/ITD AR analysis among pediatric patients with AML from the TARGET dataset. Applying fitting curve models and threshold effect analysis using the...
Topics
- Child
- Genetic Testing
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute
- Mutation
- Stem Cell Transplantation
- fms-Like Tyrosine Kinase 3
